Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1

Pediatric AIDS Clinical Trials Group 377 Study Team

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint Dive into the research topics of 'Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1'. Together they form a unique fingerprint.

Medicine & Life Sciences